As a major pathological feature of T2DM, abnormal peripheral insulin signaling is widely recognized as an important risk factor for the development of AD (Kim and Feldman, 2015) and is involved in the development of non-type 2 diabetic AD patients (Femminella et al., 2021). Here, INS is linked to Alzheimer disease.